- Details
- Description
Strength:
80 mg
Composition:
Cabozantinib 80 mg
Treatment:
Used as an anti-cancer medicine for the treatment of certain cancers, as prescribed by a qualified healthcare professional.
Form:
Capsule
Brand:
Caboxib
Quantity Unit:
Capsules
Manufacturer:
Ziska Pharmaceuticals Limited
Caboxib 80 contains Cabozantinib 80 mg, a targeted anti-cancer medicine belonging to the tyrosine kinase inhibitor class. It works by blocking specific proteins involved in cancer cell growth and tumor progression. Caboxib 80 is used in the treatment of certain cancers and should be taken only under the supervision of a qualified healthcare professional. Ziska Pharmaceuticals lists it as an anti-cancer product for export only, with a pack size of 30 capsules/tablets.
